Tag: Biopharmaceuticals

U.S. COVID vaccine program speeds up to about 3 million doses a day in the past week

The U.S. COVID-19 vaccine program continues to kick into high gear, setting a record Saturday of more than four million doses administered, although experts continue...

Single dose of AstraZeneca or Pfizer COVID-19 vaccine cuts hospitalization risk by up to 80%, study shows

A single dose of either the AstraZeneca–Oxford vaccine or the Pfizer–BioNTech COVID-19 shot cuts the risk of hospital admission among older adults by more than...

Cannabis stocks rally anew as $7 billion GW Pharma deal spurs interest in weed and its medical benefits

Cannabis stocks rallied anew on Wednesday, spurred on by news of a $7 billion deal for the first company to win U.S. regulatory approval for...

AstraZeneca vaccine may reduce spread by 67% — and protection remains over 3-month dosage gap

A single dose of the AstraZeneca AZN, -0.88% COVID-19 vaccine offers 76% protection for up to three months after the first injection and appears to...

Sanofi teams up with BioNTech and Pfizer to help fix Europe’s vaccine shortage

Sanofi SAN, +0.01% will help manufacture millions of doses of the COVID shot developed by rivals BioNTech and Pfizer PFE, +0.08% to help speed up...

Open all hours: Around-the-clock vaccination sites to be piloted in England in COVID-19 drive

The U.K. government will pilot the first 24-hour vaccination sites by the end of the January, as the country presses ahead with the biggest vaccine...

Pfizer–BioNTech vaccine appears to protect against U.K. and South African COVID-19 strains, study finds

The COVID-19 vaccine developed by Pfizer and BioNTech appears to provide protection against the new highly contagious U.K. and South African variants, according to a...

Germany accused of grabbing too much vaccine — citizens also injected with five times the recommended dosage

The European Union’s mass vaccination campaign came under fire on Tuesday, after Italians accused Germany of grabbing too much vaccine, and some care-home workers were...

FDA grants Moderna authorization for a second COVID-19 vaccine

One week after authorizing the first COVID-19 vaccine for Americans, the Food and Drug Administration granted a second emergency authorization Friday, to Moderna Inc.’s COVID-19...

First COVID-19 vaccine receives emergency approval in U.S.

The Food and Drug Administration authorized BioNTech and Pfizer Inc.’s COVID-19 vaccine Friday evening, which will make it the first vaccine to reach Americans during...

The perils of transporting millions of COVID-19 vaccines with dry ice across the U.S.

When you order a gift from Amazon AMZN, -2.30% the process of getting the item you purchased to your doorstep is fairly straightforward. But transporting...

What to expect from the FDA’s important COVID-19 vaccine meeting Thursday

An all-day regulatory meeting scheduled to take place Thursday is the next step toward the likely authorization of the first COVID-19 vaccine in the U.S....

World watches as first person receives Pfizer-BioNTech COVID shot

Manufacturing delays mean just 4 million doses of the vaccine candidate being developed by drugmaker AstraZeneca AZN, +0.97% and the University of Oxford will be...

This is why I volunteered for the Novavax COVID-19 vaccine trial, and am still cheering for the underdog

Novavax, headquartered in Rockville, Md., was the second company to enter into a late-stage trial of a COVID vaccine in the U.K. AFP via Getty...

U.K. blue chips inch higher as AstraZeneca reports vaccine effectiveness

Waves break over a wall separating the marine lake from the sea at New Brighton in northwest England on Nov. 16, 2020, as high tide...

‘Help is coming — and it’s coming soon’: Dr. Fauci outlines when COVID-19 vaccination will be available to all Americans

Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases and an expert in infectious diseases for the last four decades, gave his...

Dow, S&P 500 surge by at least 3% to records early Monday on coronavirus vaccine report

U.S. stocks soared in early trading Monday, sending major equity benchmarks to record highs after Germany-based BioNTech SE and Pfizer Inc. said their COVID-19 vaccine...

People of color shouldn’t be treated equally in COVID-19 vaccine trials, ER doctor says: They should be over-represented

This interview is part of a series of conversations MarketWatch is conducting with some of the leading voices in the U.S. on the COVID-19 pandemic....

Coronavirus update: Global COVID-19 cases top 39 million as trial of promising therapy finds it does not stop patients dying

The number of confirmed cases of the coronavirus illness COVID-19 world-wide climbed above 39.4 million on Saturday, a day after a clinical trial found one...

Regeneron CEO cautions Trump’s results are ‘a case of one,’ and coronavirus drug needs more testing

Regeneron Pharmaceuticals has submitted a request for emergency authorization to the FDA for its experimental antibody treatment for coronavirus. Getty Images/iStockphoto illustration President Donald Trump...

Trump physicians have administered a steroid used to treat severely ill COVID-19 patients

President Donald Trump, who on Friday disclosed he had tested positive for the coronavirus, is now being treated with dexamethasone, a steroid that is primarily...

‘I wasn’t feeling so well. I feel much better now’: Full transcript of Trump’s video address from Walter Reed

President Donald Trump released a video statement from Walter Reed medical center late Saturday, telling the public that he was now feeling much better. “I...

‘Just stay calm. It will go away’: A look back at Trump’s shifting stance on face masks and on the threat of COVID-19

President Donald Trump was transported on Marine One from the White House to Walter Reed Hospital late Friday, the same day that he and first...

There are four coronavirus vaccines in late-stage studies — here’s how they differ

Johnson & Johnson’s investigational COVID-19 vaccine entered Phase 3 clinical trials this week, making it the fourth vaccine candidate in the U.S. to do so...

The COVID-19 pandemic is about to enter its most treacherous phase

BERKELEY, Calif. (Project Syndicate)—April marked the most dramatic and, some would say, dangerous phase of the COVID-19 crisis in the United States. Deaths were spiking,...